Marilena Vrana/LinkedIn
Oct 5, 2025, 11:50
Marilena Vrana: Europe’s Plasma Supply Chain is at a Critical Juncture, and Current Policies are not Equipped to Fix it
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“Europe’s plasma supply chain is at a critical juncture, and current policies are not equipped to fix it.
In my latest opinion piece The Brussels Times, I break down why plasma-derived medicines require a holistic policy approach – especially as the Critical Medicines Act takes shape.
- Europe’s dependence on US plasma
- Why PDMPs don’t fit policies designed to tackle supply chains of chemically synthesized pharmaceuticals
- The pitfalls of “one-size-fits-all” approach
- The importance of collaboration
If we, Europeans, aim to achieve strategic autonomy and security of medicines supply, our policies must be grounded in reality.
International Plasma Awareness Week, which starts on October 6th, offers the perfect moment to reset Europe’s approach.”

Read more here.
Stay updated with Hemostasis Today.
-
Aug 20, 2026, 04:42Chris Zahner: Why Healthy People Can Have Abnormal Lab Results
-
Aug 20, 2026, 03:57Reza Shojaei: What the First U.S. Freeze-Dried Plasma Approval Means
-
Aug 20, 2026, 01:23Jessica Erley: Understanding Patient Experience Beyond the Clinical Encounter
-
Aug 20, 2026, 01:19Dries De Wolf: Innovative Gene Therapy for Hemophilia B
-
Aug 19, 2026, 19:09Gregory Lip: PFO Closure in Younger Patients With Cryptogenic Stroke
-
Aug 19, 2026, 18:51Filippo Crea: AF and Alzheimer’s Disease – Does the Anticoagulant Choice Matter for the Brain?
-
Aug 19, 2026, 18:42Alan Nurden: How Procoagulant Platelets Relate to Microparticle Release?
-
Aug 19, 2026, 18:25Ivan Centeno Sáenz: FeNO and Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease
-
Aug 19, 2026, 18:10Ahmad Hazri Mohamed Aris: Strengthening Hemophilia Care and Access to Treatment in Fiji